DNLI
Common StockDenali Therapeutics Inc.
Healthcare
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$27.1M
Portfolio Weight
92.48%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$29.3M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
DNLI
Common StockDenali Therapeutics Inc.
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$27.1M
Portfolio Weight
92.48%
SANA
Common StockSana Biotechnology, Inc.
Reported Shares
755.7K
Position Mix
No options reported
Reported Value
$2.2M
Portfolio Weight
7.52%